← All indications
Anovulation
Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries (OVARIAN FOLLICLE). Depending on the etiology, OVULATION may be induced with appropriate therapy.
Drugs by status
Approved for this indication (3)
Phase 4 trials (6)
Phase 3 trials (2)
Phase 2 trials (2)
Phase 1 trials (2)
Other trials (5)
Organizations
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (24)
- Merck Serono
- Merck KGaA
- Dong-A Pharmaceutical
- Sun Pharmaceuticals
- GeneScience Pharmaceuticals Co., Ltd.
- United States Army
- United States Air Force
- Huazhong University of Science and Technology
- Ajou University
- Central South University
- Benha University
- Gachon University
- Jilin University
- Seoul National University
- Shengjing Hospital
- University of Oklahoma
- Peking University
- Wenzhou Medical University
- Dalian Medical University
- University of Ulsan
- Shandong University
- Sungkyunkwan University
- Ferring
- Dongguk University
Organization Involved with Phase 2 Indications (6)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (6)